Clinical trial · Interventional
Improving Patient Understanding of Their Prostate Cancer Diagnosis Using AI
Can Artificial Intelligence Help Improve Patient Understanding of Their Diagnosis? Using ChatGPT as an Interactive Chatbot for Patients With Localized Prostate Cancer, a Feasibility Study
NCT07040501CI-TRIAL-00109939not yet recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to determine if ChatGPT (an artificial intelligence driven chatbot) can help patients better understand their own pathology results and prostate cancer diagnosis.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Chat GPT | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Chat GPT - Prostate Pathology Guide
- interventionNames
- Device: Chat GPT
Primary outcomes (1)
- measure
- Accuracy as assessed by the rate of correctly identified and risk-stratified participants diagnosed with prostate cancer
- timeFrame
- Post intervention(approximately 70 minutes)
Secondary outcomes (3)
- measure
- Patient anxiety as measured by Visual analog scale(VAS-A)
- timeFrame
- Baseline and post intervention(approximately 70 minutes)
- description
- VAS-A: Answers rated on scale of 0 to 100 - where 0 is not at all anxious and 100 is extremely anxious
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 19 Years
Show eligibility criteria text
Inclusion Criteria: * Participants must be \>18 years or age * Participants must have received a prostate biopsy at Cleveland Clinic main campus within the last 30 days, and have not received follow-up on their pathology results * Participants must be willing to attend an in-person follow-up to review their pathology * Participants must be English speaking * Participants must provide informed consent Exclusion Criteria: • Participants who do not meet the inclusion criteria, as stated above
References
Publications (0)
Data not yet available
No reference posted for this study.